Matthew Eyes, president and CEO of America’s Health Insurance Plans, says a recent blog post on pharmacy benefit managers and their role in drug prices misses on key fact: pharma companies set the prices.
Eyes’ blog post on Health Affairs was in response to Michael Carrier’s Aug. 30 post, “A Six-Step Solution to the PBM Problem.”
Pharmacy benefit managers, he writes, play a key role in drug pricing negotiations for lower prices, savings from which are “passed on through lower premiums and lower out-of-pocket costs that we offer our members.”
“However, drug prices continue to rise because competition is limited, and there often are no alternatives to the life-saving medications patients need,” Eyes writes.
Eyes, citing an Associated Press report, notes that in the first seven months this year there were 96 price increases on prescription drugs for every price drop.
To read Eyes’ full blog post, click here.